Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona Browne

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
The British Journal of Dermatology|April 9, 2024
Midfacial toddler excoriation syndrome (MiTES): case series, diagnostic criteria and evidence for a pathogenic mechanismNivedita Sarveswaran, Yunisa Pamela, Akhila A N Reddy, et al.
The British Journal of Dermatology|September 18, 2023
Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trialCarsten Flohr, Anna Rosala-Hallas, Ashley P Jones, et al.
The British Journal of Dermatology|July 15, 2024
The effects of ciclosporin and methotrexate on kidney function in the treatment of severe atopic dermatitis in children: results from the TREAT trialGordon Bruce, Anna Rosala-Hallas, Ashley P Jones, et al.
Clinical and Experimental Dermatology|April 1, 2025
Exposure-response of ciclosporin and methotrexate in children and young people with severe atopic dermatitis: A secondary analysis of the TREatment of severe Atopic dermatitis Trial (TREAT)Mandy Wan, Ashley P Jones, Daniel Maskrey, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
The British Journal of Dermatology|April 9, 2024
Midfacial toddler excoriation syndrome (MiTES): case series, diagnostic criteria and evidence for a pathogenic mechanismNivedita Sarveswaran, Yunisa Pamela, Akhila A N Reddy, et al.
The British Journal of Dermatology|September 18, 2023
Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trialCarsten Flohr, Anna Rosala-Hallas, Ashley P Jones, et al.
The British Journal of Dermatology|July 15, 2024
The effects of ciclosporin and methotrexate on kidney function in the treatment of severe atopic dermatitis in children: results from the TREAT trialGordon Bruce, Anna Rosala-Hallas, Ashley P Jones, et al.
Clinical and Experimental Dermatology|April 1, 2025
Exposure-response of ciclosporin and methotrexate in children and young people with severe atopic dermatitis: A secondary analysis of the TREatment of severe Atopic dermatitis Trial (TREAT)Mandy Wan, Ashley P Jones, Daniel Maskrey, et al.
Pageof 4